Five Feet Apart Quiz | Eight Week Quiz E

Rachael Lippincott
This set of Lesson Plans consists of approximately 142 pages of tests, essay questions, lessons, and other teaching materials.
Related Topics

Five Feet Apart Quiz | Eight Week Quiz E

Rachael Lippincott
This set of Lesson Plans consists of approximately 142 pages of tests, essay questions, lessons, and other teaching materials.
Buy the Five Feet Apart Lesson Plans
Name: _________________________ Period: ___________________

This quiz consists of 5 multiple choice and 5 short answer questions through Chapters 15-19.

Multiple Choice Questions

1. According to his conversation with Will in Chapter 12, when was the last time Poe saw his family?
(a) 5 years ago.
(b) 2 years ago.
(c) 6 months ago.
(d) 1 year ago.

2. What realization does Will come to at the end of Chapter 14?
(a) He can lead a fulfilling life even with CF.
(b) He is doomed.
(c) He is very dangerous to Stella.
(d) His treatment is worthless.

3. Will is part of a trial for a new drug named what?
(a) Orkambi.
(b) Kalydeco.
(c) Pulmozyme.
(d) Cevaflomalin.

4. What is the name of Poe's ex-boyfriend, whom Poe really liked?
(a) Mack.
(b) Michael.
(c) Morris.
(d) Mitchell.

5. At the end of Chapter 19, what plan does Stella begin to formulate?
(a) A plan to escape the hospital.
(b) A plan to raise money for Poe.
(c) A plan to get lungs for Will.
(d) A plan for Will's birthday.

Short Answer Questions

1. What is Abby clutching in the video Stella watches in Chapter 9?

2. While in Will's room in Chapter 7, what is Stella surprised to see?

3. What has Will made for Stella in Chapter 15, as she is recovering from surgery?

4. In Chapter 6, Will tells Stella that he will follow his treatment regimen, but only if she agrees to do what?

5. As Chapter 7 opens, what has Will managed to secure for himself?

(see the answer key)

This section contains 272 words
(approx. 1 page at 300 words per page)
Buy the Five Feet Apart Lesson Plans
Copyrights
BookRags
Five Feet Apart from BookRags. (c)2026 BookRags, Inc. All rights reserved.